Difference between revisions of "Mutual Recognition Agreements (MRA)"

Revision as of 23:11, 3 March 2008 (view source) STUART KING (talk \| contribs)		Latest revision as of 15:36, 4 March 2008 (view source) STUART KING (talk \| contribs) m
(One intermediate revision by the same user not shown)
Line 1:		Line 1:
−	This is the activity of European Commission whereby in the context of the EU pharmaceutical industry, MRAs faciliate the international trading of pharmaceutical products. Essentially, MRAs set out the conditions between the EU and other countries in the trading and promoting of pharmaceuticals. The Commission's pharmaceutical unit play an important role in actively promoting the trading of such products between the EU and countries on a global scale, e.g. Canada, the US, Australia, New Zealand, Switzerland and Japan. <ref> MRA http://ec.europa.eu/enterprise/pharmaceuticals/mra/index.htm Accessed 1/03/08 </ref> <ref> Mutual recognition agreements http://ec.europa.eu/enterprise/international/index_en.htm Accessed 1/03/08 </ref> <ref> Pharmaceuticals: regulatory framework and market authorisations http://ec.europa.eu/enterprise/pharmaceuticals/mra/doc/statusreport20030717.pdf Accessed 1/03/08 </ref>	+

Latest revision as of 15:36, 4 March 2008